Halo Collective Plans to Expand Retail Space after Record Sales

Nov.23.2022
Halo Collective Plans to Expand Retail Space after Record Sales
Halo Collective reports highest sales quarter and plans to expand Budega retail stores, aiming for seven more locations in the US by 2023.

During this quarter, Halo Collective experienced its highest reported sales and continues to plan expansion with the successful opening of its first two Budega retail stores. The opening of the third supermarket store has made significant progress.


After reviewing its current operations, the company is actively seeking additional retail space and licenses in the United States, with a goal of securing up to seven locations by the end of 2023. Retail stores represent a valuable resource for sales and customer data, as they allow for vertical integration and offer a range of cannabis-related products, including food, pre-rolls, e-cigarettes, flowers, tinctures, creams, and more.


The company has successfully acquired three locations in the California area, including Westwood, NoHo, and now Hollywood, and plans to open seven more stores next year. Since its opening in early March of this year, the NoHo store has continued to grow with steady increases in revenue, offering unique promotional events to drive consumer traffic while maintaining a loyal and consistent customer base. In October of last year, the company implemented innovative changes to increase the stores' net profit. All retail locations promote their own products, including the top-selling Budega and Hush flower brands.


Westwood has experienced rapid growth over the past six months, with monthly revenues nearly doubling and peaking in sales in October of last year. Sales in the third quarter increased by 94% compared to the second quarter, and the company anticipates fourth quarter sales in Westwood to be based on October's sales figures. The pharmacy is conveniently located between Westwood and Beverly Hills, adjacent to Santa Monica Boulevard in a high-traffic area. Westwood is also the nearest pharmacy to the tourist areas of Beverly Hills and Century City.


Budega, a retail brand in the California cannabis industry, has established its presence as a prominent player. Following positive initial evaluations, the company is continuing its expansion plans in the region next year. Budega Hollywood, the largest of its three stores, has made significant progress and is projected to generate $15 million in revenue by 2023. The company has hired a renowned contractor to oversee the store's expansion and design, and has approved renderings to move forward with the development.


Regarding Halo Collective


Halo is a company that focuses on the west coast of the United States and vertically integrates its business, covering the entire value chain from seed to sale. The company grows, extracts, manufactures, and distributes high-quality cannabis flowers, pre-rolls, vape carts, edibles, and concentrates. These products are sold under a range of brands, including Hush™, Winberry Farms™, their retail brand Budega™, as well as through a licensing agreement with FlowerShop*. Additionally, Halo has opened two dispensaries under the Budega™ brand in North Hollywood and Hollywood, with plans to open another in Hollywood in 2022.


In the non-THC space, Halo is expanding into the health and wellness categories, including CBD and functional supplements such as brain-boosting nutrition products and non-psychedelic mushrooms. Through a series of acquisitions, Halo offers products in the form of beverages (H2C Beverages), dissolvable strips (Dissolve Medical), capsules (Hushrooms™), and topical supplements (Hatshe), and plans to distribute nationally through a strategic agreement with SWAY Energy.


Halo has successfully acquired and integrated multiple companies, subsequently restructuring to create Akanda Corp. (NASDAQ stock code: AKAN), an international medical cannabis and health company in which Halo is the largest shareholder. Halo has also acquired a series of software development assets including CannPOS, Cannalift, CannaFeels, and discrete sublingual delivery technology Accudab. Halo intends to restructure these entities (including their intellectual property and patent applications) into a subsidiary named Halo Tek Inc. and complete the distribution of Halo Tek Inc. shares to registered shareholders on a date to be determined.


Statement:


This article is compiled from third-party information and is only intended for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness and accuracy of the content. The translation of this article is only intended for communication and research within the industry.


Due to limitations in the compiler's proficiency, the translated article may not fully reflect the intended meaning of the original. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign issues and stances.


5. The copyright of the compiled information belongs to the original media and authors. If there is infringement, please contact for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09